Tonix Pharmaceuticals stock halted ahead of FDA approval news
On Wednesday, Truist Securities increased its price target for Palomar Holdings (NASDAQ:PLMR) shares from $178.00 to $188.00, while keeping a Buy rating on the stock. The firm’s analyst, Mark Hughes, cited a positive outlook on the company’s earnings potential, leading to the adjustment in the price target. The optimism appears well-founded, as InvestingPro data shows Palomar’s stock has surged 83.68% over the past year, currently trading near its 52-week high at $160.50.
Hughes has raised the earnings per share (EPS) estimates for Palomar Holdings for the years 2025 and 2026. The new estimates are $7.00 for 2025, up from the previous $6.65, and $8.30 for 2026, an increase from $7.90. The analyst’s optimism is partly based on the potential for Palomar to benefit from lower reinsurance costs in the near term. These costs are expected to be revealed around June 1st. The company’s current diluted EPS stands at $5.02, with InvestingPro analysts projecting $6.93 for fiscal year 2025, indicating strong earnings momentum.
According to Hughes’ analysis, if Palomar can achieve a 500 basis points improvement over its current guidance, which aims for a flat-to-down 5%, this could lead to a 4% increase in EPS. The revised price target of $188 is based on the stock trading at 23 times the firm’s 2026 earnings estimate. This valuation is at the higher end of the spectrum for the specialty property and casualty (P&C) insurance group.
Truist Securities believes that the premium valuation is justified for Palomar Holdings given the company’s robust top-line growth and solid returns. The firm’s price target implies confidence in Palomar’s performance and prospects within the specialty P&C sector.
In other recent news, Palomar Holdings Inc . reported a notable earnings performance for the first quarter of 2025. The company’s adjusted earnings per share (EPS) reached $1.87, surpassing analysts’ expectations of $1.62. Palomar also experienced a 20% increase in gross written premiums, amounting to $442.2 million, although revenue slightly missed forecasts at $442.16 million compared to the anticipated $449.87 million. The company raised its full-year 2025 adjusted net income guidance to a range of $186 million to $200 million, reflecting optimism about its growth trajectory. Palomar’s strategic initiatives, such as the expansion of its crop insurance and casualty lines, have contributed to its strong performance, with casualty gross written premiums surging by 113%. The company continues to focus on its Palomar 2X strategic imperative, which aims to build a leading specialty insurance franchise. Analysts have noted the company’s effective cost management and strategic growth in high-margin segments, despite some economic uncertainties and potential growth headwinds.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.